Hard to see too much happening T/O or licensing wise until phase...

Hard to see too much happening T/O or licensing wise until phase 2b trials are well advanced. I'd say when they do the interim readout things will get tasty, possibly late 2018. Full read out 1H 2019. I'd say within 12 months from now. And if the 2b results are anything like 2a results, it will be much more than 10 bags.

Just a matter of patience. Our management team know what they are doing. Unfortunately they just can't complete clinical trials within a fortnight, like some here expect. Read between the lines and you will see a lot has happened and a lot is happening in the background. Dimerix doing all the hard yards and some big pharma entity will swoop when the time is right. Now would be cheaper for them but during/post phase 2b is more derisked for them. Set and forget